Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Whitaker

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Gastroenterology & Hepatology|February 7, 2003
Proton pump inhibitors in the elderly populationMark Whitaker
The Laryngoscope|May 3, 2007
Antibiotic prophylaxis in cochlear implant surgeryBarry E Hirsch, Athanasios Blikas, Mark Whitaker
Ear, Nose, & Throat Journal|May 20, 2026
Role of Hearing Loss in Otolaryngology Surgical OutcomesQuentin C Durfee, Hänel W Eberly, David Goldrich, et al.
Ear, Nose, & Throat Journal|March 30, 2026
Quality and Reliability of YouTube Videos for Patient Education in Stapedectomy and StapedotomyQuentin C Durfee, Hänel W Eberly, Bao Y Sciscent, et al.
Pharmaceutical Research|January 6, 2022
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE TechnologyDebra Tompson, Mark Whitaker, Rennan Pan, et al.
Pharmaceutical Research|June 17, 2021
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772Debra J Tompson, Mark Whitaker, Rennan Pan, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2009
A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic propertiesNeil Moss, Younggi Choi, Derek Cogan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|February 7, 2003
Proton pump inhibitors in the elderly populationMark Whitaker
The Laryngoscope|May 3, 2007
Antibiotic prophylaxis in cochlear implant surgeryBarry E Hirsch, Athanasios Blikas, Mark Whitaker
Ear, Nose, & Throat Journal|May 20, 2026
Role of Hearing Loss in Otolaryngology Surgical OutcomesQuentin C Durfee, Hänel W Eberly, David Goldrich, et al.
Ear, Nose, & Throat Journal|March 30, 2026
Quality and Reliability of YouTube Videos for Patient Education in Stapedectomy and StapedotomyQuentin C Durfee, Hänel W Eberly, Bao Y Sciscent, et al.
Pharmaceutical Research|January 6, 2022
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE TechnologyDebra Tompson, Mark Whitaker, Rennan Pan, et al.
Pharmaceutical Research|June 17, 2021
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772Debra J Tompson, Mark Whitaker, Rennan Pan, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2009
A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic propertiesNeil Moss, Younggi Choi, Derek Cogan, et al.
Pageof 1